| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Common Stock | Options Exercise | $0 | +3K | +1.84% | $0.00 | 166K | Mar 16, 2024 | Direct | F1 |
| transaction | AXGN | Common Stock | Sale | -$5.5K | -716 | -0.43% | $7.68 | 166K | Mar 21, 2024 | Direct | F2 |
| transaction | AXGN | Common Stock | Options Exercise | $0 | +2.95K | +1.78% | $0.00 | 169K | Mar 16, 2024 | Direct | F1 |
| transaction | AXGN | Common Stock | Sale | -$5.54K | -721 | -0.43% | $7.68 | 168K | Mar 21, 2024 | Direct | F2 |
| transaction | AXGN | Common Stock | Options Exercise | $0 | +12.7K | +7.58% | $0.00 | 181K | Mar 16, 2024 | Direct | F1 |
| transaction | AXGN | Common Stock | Sale | -$24.1K | -3.14K | -1.74% | $7.68 | 177K | Mar 21, 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Restricted Stock Units | Options Exercise | $0 | -3K | -100% | $0.00* | 0 | Mar 16, 2024 | Common Stock | 3K | Direct | F3, F4 | |
| transaction | AXGN | Restricted Stock Units | Options Exercise | $0 | -2.95K | -50% | $0.00 | 2.95K | Mar 16, 2024 | Common Stock | 2.95K | Direct | F3, F5 | |
| transaction | AXGN | Restricted Stock Units | Options Exercise | $0 | -12.7K | -50% | $0.00 | 12.7K | Mar 16, 2024 | Common Stock | 12.7K | Direct | F3, F6 |
| Id | Content |
|---|---|
| F1 | This reflects the number of restricted stock units that became vested as of March 16, 2024. |
| F2 | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| F3 | Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. |
| F4 | All shares of Axogen Inc. common stock underlying the restricted stock units vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022, 25% of the aggregate shares vest on March 16, 2023, and 25% of the aggregate shares vest on March 16, 2024. Vested shares will be delivered to the reporting person upon the vesting date. |
| F5 | All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date. |
| F6 | All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. |